[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Acorai AB\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":56},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,35],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":23,"whyStopped":4,"lastUpdateSubmitDate":24,"lastUpdatePostDateStruct":25,"startDateStruct":28,"completionDateStruct":30,"leadSponsor":32,"locationsCount":4},"100593755",false,"NCT07010562","A Multi-site, Prospective, Non-interventional, Observational Data Collection Study in Patients Undergoing a Right Heart Catheterization","Inclusion Criteria:\n\n* Subject is at least 18 years of age at the time of screening.\n* Subject is willing and physically able to comply with the specified evaluations as per the protocol.\n* Subject is referred for invasive hemodynamic assessment with right heart catheterization.\n* Subject has provided written informed consent using the approved consent form.\n\nExclusion Criteria:\n\n* Discretionary exclusion when the inclusion of a potential subject is not in their best interest or not in the interest of compliant performance of the study.","ALL","18 Years",{"count":17,"type":18},392,"ESTIMATED","OBSERVATIONAL","Acorai is developing a non-invasive monitoring system for the estimation of intracardiac hemodynamic parameters in patients with suspected or confirmed heart failure, and\u002For pulmonary hypertension, who require hemodynamic assessment. The device will be intended as a companion test or clinical decision support tool to be used and interpreted by qualified healthcare professionals to aid standard-of-care clinical assessment in identifying hemodynamic congestion and supporting personalized treatment of heart failure and pulmonary congestion.\n\nThis study is part of the development of a non-invasive monitoring system for the estimation of intracardiac hemodynamic parameters. It will be conducted to collect the data needed to train the machine learning models retrospectively.",[22],"Heart Failure","NOT_YET_RECRUITING","2026-06-26",{"date":26,"type":27},"2026-06-30","ACTUAL",{"date":29,"type":18},"2026-07-01",{"date":31,"type":18},"2027-02-28",{"name":33,"class":34},"Acorai AB","INDUSTRY",{"id":36,"slug":4,"hasResults":10,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":4,"eligibilityCriteria":40,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":41,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":43,"conditions":44,"keywords":4,"overallStatus":47,"whyStopped":4,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":55},"100644611","NCT07671742","Non-Invasive Hemodynamic Monitoring in Hospitalized Heart Failure","Hemodynamic Observational Study in Patients With Heart Failure Using a Non-Invasive Multi-Modal Sensing Device (HOSP-HF)","Inclusion Criteria:\n\n* Age ≥18 years\n* Hospitalization for primary heart failure, defined as new or worsening heart failure symptoms with objective evidence of congestion requiring initiation or intensification of heart failure-specific therapy\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Any discretionary exclusion where the inclusion of the subject is deemed to pose potential risks to the subject's well-being or is likely to comprise the compliant performance of the study.\n* Pregnancy or lactation (as confirmed by self-report or medical documentation)\n* Presence of a skin rash or open wound in the area where the Acorai Device model 1.0 will be applied\n* Any other condition that, in the opinion of the investigator, would preclude the subject from participating in the study or may affect the integrity of the data",{"count":42,"type":18},1000,"Heart failure hospitalization is associated with a high risk of early readmission and mortality. There is an unmet clinical need for low-burden, non-invasive methods to better understand congestion and hemodynamic status during hospitalization.\n\nThis observational study evaluates the association between non-invasive measurements obtained with the Acorai Device 1.0 and clinical data collected during hospitalization and up to 90 days after discharge in patients admitted with heart failure. The device performs short, non-invasive recordings that collect physiological signals from the thoracic region without influencing clinical care.\n\nParticipants will undergo daily recordings during hospitalization. Clinical information and outcomes, including heart failure hospitalization and all-cause mortality within 90 days after discharge, will be collected from medical records. The study aims to explore relationships between non-invasive sensor measurements and clinical outcomes in hospitalized heart failure patients.",[22,45,46],"Heart Failure Hospitalization","Heart Failure (HF)","RECRUITING","2026-06-23",{"date":24,"type":27},{"date":51,"type":27},"2026-04-01",{"date":53,"type":18},"2027-04-01",{"name":33,"class":34},1,""]